Join to View Full Profile
506 Graham DrSte 120Tomball, TX 77375
Phone+1 281-516-0236
Fax+1 281-719-5930
Dr. Jeong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006- Westchester Medical CenterResidency, Internal Medicine, 2000 - 2003
Catholic University Medical CollegeClass of 1998
Certifications & Licensure
TX State Medical License 2014 - 2025
NY State Medical License 2010 - 2015
NJ State Medical License 2010 - 2013
ME State Medical License Active through 2011
American Board of Internal Medicine Medical Oncology
Clinical Trials
- S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Start of enrollment: 2015 May 07
- A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification Start of enrollment: 2015 Sep 23
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Burned-Out Testicular Germ Cell Tumor Presenting as Retroperitoneal Lymphadenopathy in a Patient With Cryptorchidism: A Case Report & Review of Literature.Soroush Shahrokh, Michelle Hebert, Woondong Jeong, Shan Guo
Cureus. 2022-07-01 - 5 citationsCombination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.S. Kummar, Apurva K. Srivastava, Tony Navas, Fabiola Cecchi, Young H. Lee
Investigational New Drugs. 2021-06-28 - 3 citationsEffect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysisSalvador Fudio, Josep Tabernero, Vivek Subbiah, Sant P. Chawla, Victor Moreno
Cancer Chemotherapy and Pharmacology. 2021-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
